Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Speciality Chemicals
  4. /Anupam Rasayan India Ltd
MomentumDeep Value

Anupam Rasayan India Ltd: Why Is It Outperforming Nifty 500?

Active
WeakRe-Entry

In Week of Mar 28, 2026, Anupam Rasayan India Ltd (Speciality Chemicals) is outperforming Nifty 500 with +5.0% relative strength. Fundamentals: Weak.

PE: At PeakEmerging Opportunity

What's Happening

⏳Steady earner with flat PE — waiting for re-rate catalyst
💪Debt reduced 11% YoY — balance sheet strengthening
👔Promoter stake down 2.2% this quarter
🌐FII stake increased 0.6% this quarter
💰Trading 57% above estimated fair value — significant premium

Earnings Acceleration Triggers

1. Jayhawk integration completion
Q4 FY26HIGH
2. Mundra Phase II capacity ramp-up
Q1-Q2 FY27MEDIUM
3. API product mix shift
Q2-Q3 FY27MEDIUM

Key Risks

1. RM volatility for benzene derivatives
MEDIUM
2. Competitive capacity additions
LOW

Key Numbers

PAT Growth YoY
+13%
Stable
Revenue YoY
+31%
Stable
Operating Margin
25.0%
-700 bps YoY
PE Ratio
81.6
Current Price
₹1,234
Dividend Yield
0.06%
Fundamental Score
23/100
Weak
3Y PAT CAGR
+2%
Market Cap
14.0K Cr
Valuation
Significantly Overvalued

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

Why Are Anupam Rasayan India Ltd's Earnings Accelerating?

Based on Q3 FY26 earnings • Updated Feb 22, 2026

Jayhawk integration completion

Expected: Q4 FY26HIGH confidence+₹110 Cr revenue

What: Full integration adding ₹450 cr annual revenue at 25%+ OPM

Impact: +₹110 Cr revenue

“MD stated: 'The Jayhawk integration is now complete and we've already secured long-term contracts with three global agrochemical majors. This facility will contribute approximately ₹110 crores in Q4 itself with margins significantly above our company average.'”

Mundra Phase II capacity ramp-up

Expected: Q1-Q2 FY27MEDIUM confidence+₹300 Cr revenue

What: 50,000 MT capacity adding ₹300 cr revenue at 23% OPM

Impact: +₹300 Cr revenue

“MD stated: 'Our new state-of-the-art facility at Mundra is scheduled to be commissioned by March 2026. We have already secured LOIs covering 70% of the capacity from existing customers looking to diversify their supply chain away from China.'”

API product mix shift

Expected: Q2-Q3 FY27MEDIUM confidence+₹200 Cr revenue

What: New high-margin APIs boosting OPM by 300-400 bps

Impact: +₹200 Cr revenue

“MD stated: 'We've successfully developed three new API molecules that are currently in the validation stage with global pharma companies. These products carry margins in excess of 30% and will constitute 15-20% of our revenue mix within 18 months.'”

What Are the Key Risks for Anupam Rasayan India Ltd?

Earnings deceleration risks from management commentary

RM volatility for benzene derivatives

MEDIUM

Trigger: Prolonged supply disruption from China

Impact: -175 bps margin impact

Management view: CFO noted price adjustment clauses in contracts to mitigate risk

Monitor: Benzene derivative prices and inventory days

Competitive capacity additions

LOW

Trigger: Rapid competitor capacity ramp-up

Impact: -100 bps margin impact

Management view: MD cited regulatory moats providing pricing power

Monitor: Competitor capex announcements and pricing trends

What Is Anupam Rasayan India Ltd's Management Saying?

Key quotes from recent conference calls

“The Jayhawk integration is now complete and we've already secured long-term contracts with three global agrochemical majors. This facility will contribute approximately ₹110 crores in Q4 itself with margins significantly above our company average. — Anand Desai”
“We've invested ₹650 crores in capex this year, primarily toward the Jayhawk integration and Mundra expansion. Our total capex for FY26 will be around ₹800 crores with returns expected to materialize from Q4 onwards. — Anand Desai”
“Our OPM expansion to 22.5% reflects both operating leverage and our successful transition to higher-value products. We expect margins to further improve to 23-24% range in the next 4 quarters. — Gopal Agarwal”
“Our order book stands at ₹4,200 crores, providing us with 5+ quarters of revenue visibility. This is the highest in our company's history. — Anand Desai”

What Is Anupam Rasayan India Ltd's Management Guidance?

Forward-looking targets from management for FY27

Revenue Growth Target

35%

Implied PAT Growth

38%

OPM Guidance

23.5%

Capex Plan

₹800 Cr

Management Tone: BULLISH

Key Milestones

• Jayhawk integration completion

• Mundra Phase II ramp-up

• API product commercialization

How Fast Is Anupam Rasayan India Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+31%+10%Stable
PAT (Net Profit)+13%+2%Stable
OPM25.0%-700 bpsVolatile

The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Feb 22, 2026.

Other Top Speciality Chemicals Stocks Beating Nifty 500

Aether Industries Ltd
Weak • 12w streak
+49.8%
Aarti Industries Ltd
Average • 8w streak
+22.5%
← Back to Speciality ChemicalsDashboard

Frequently Asked Questions: Anupam Rasayan India Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Anupam Rasayan India Ltd's latest quarterly results?

Anupam Rasayan India Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +13.0% (stable)
  • Revenue Growth YoY: +31.3%
  • Operating Margin: 25.0% (volatile)

Is Anupam Rasayan India Ltd's profit growing or declining?

Anupam Rasayan India Ltd's profit is growing with an stable trend.

  • PAT Growth YoY: +13.0% (latest quarter)
  • PAT Growth QoQ: +7.0% (sequential)
  • 3-Year PAT CAGR: +1.7%
  • Trend: Stable — consistent growth pattern

What is Anupam Rasayan India Ltd's revenue growth trend?

Anupam Rasayan India Ltd's revenue growth trend is stable.

  • Revenue Growth YoY: +31.3%
  • Revenue Growth QoQ: -30.0% (sequential)
  • 3-Year Revenue CAGR: +10.2%

How is Anupam Rasayan India Ltd's operating margin trending?

Anupam Rasayan India Ltd's operating margin is volatile.

  • Current OPM: 25.0%
  • OPM Change YoY: -7.0% basis points
  • OPM Change QoQ: +6.0% basis points

What is Anupam Rasayan India Ltd's 3-year profit and revenue CAGR?

Anupam Rasayan India Ltd's long-term compounding rates

  • 3-Year Profit CAGR: +1.7%
  • 3-Year Revenue CAGR: +10.2%

Is Anupam Rasayan India Ltd's growth accelerating or decelerating?

Anupam Rasayan India Ltd's earnings growth is stable with mixed signals on a sequential basis.

  • YoY Acceleration: -70.9% bps
  • Sequential Acceleration: -11.8% bps
  • Margin Warning: Operating margins are under pressure

What is Anupam Rasayan India Ltd's trailing twelve month (TTM) performance?

Anupam Rasayan India Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹229 Cr
  • TTM PAT Growth: +67.2% YoY
  • TTM Revenue: ₹2,000 Cr
  • TTM Revenue Growth: +66.5% YoY
  • TTM Operating Margin: 24.1%

Is Anupam Rasayan India Ltd overvalued or undervalued?

Anupam Rasayan India Ltd appears significantly overvalued based on our fair value analysis.

  • Valuation Signal: Significantly Overvalued
  • Current PE: 81.6x
  • Price-to-Book: 4.4x

What is Anupam Rasayan India Ltd's current PE ratio?

Anupam Rasayan India Ltd's current PE ratio is 81.6x.

  • Current PE: 81.6x
  • Market Cap: 14.0K Cr
  • Dividend Yield: 0.06%

How does Anupam Rasayan India Ltd's valuation compare to its history?

Anupam Rasayan India Ltd's current PE is 81.6x.

  • Current PE: 81.6x
  • Valuation Assessment: Significantly Overvalued

What is Anupam Rasayan India Ltd's price-to-book ratio?

Anupam Rasayan India Ltd's price-to-book ratio is 4.4x.

  • Price-to-Book (P/B): 4.4x
  • Book Value per Share: ₹281
  • Current Price: ₹1234

Is Anupam Rasayan India Ltd a fundamentally strong company?

Anupam Rasayan India Ltd is rated Weak with a fundamental score of 22.57/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: +31.3% (10% weight)
  • PAT Growth YoY: +13.0% (10% weight)
  • PAT Growth QoQ: +7.0% (10% weight)
  • Margins stable (10% weight)

Is Anupam Rasayan India Ltd debt free?

Anupam Rasayan India Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹1,000 Cr

What is Anupam Rasayan India Ltd's return on equity (ROE) and ROCE?

Anupam Rasayan India Ltd's return ratios over recent years

  • FY2023: ROCE 13.0%
  • FY2024: ROCE 9.0%
  • FY2025: ROCE 7.0%

Is Anupam Rasayan India Ltd's cash flow positive?

Anupam Rasayan India Ltd's operating cash flow is negative (FY2025).

  • Cash from Operations (CFO): ₹-30 Cr
  • Free Cash Flow (FCF): ₹-360 Cr
  • CFO/PAT Ratio: -19% (weak cash conversion)

What is Anupam Rasayan India Ltd's dividend yield?

Anupam Rasayan India Ltd's current dividend yield is 0.06%.

  • Dividend Yield: 0.06%
  • Current Price: ₹1234

Who holds Anupam Rasayan India Ltd shares — promoters, FII, DII?

Anupam Rasayan India Ltd's shareholding pattern (Dec 2025)

  • Promoters: 59.1%
  • FII (Foreign): 7.6%
  • DII (Domestic): 0.4%
  • Public: 32.9%

Is promoter holding increasing or decreasing in Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 59.1% (Dec 2025)
  • Previous Quarter: 59.1% (Sep 2025)
  • Change: 0.00% (stable)

How long has Anupam Rasayan India Ltd been outperforming Nifty 500?

Anupam Rasayan India Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.

Is Anupam Rasayan India Ltd a new momentum entry or an established outperformer?

Anupam Rasayan India Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.

What are the growth catalysts for Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd has 3 key growth catalysts identified from recent earnings analysis

  • Jayhawk integration completion
  • Mundra Phase II capacity ramp-up
  • API product mix shift

What are the key risks in Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd has 2 key risks worth monitoring

  • RM volatility for benzene derivatives
  • Competitive capacity additions

What did Anupam Rasayan India Ltd's management say in the latest earnings call?

In Q3 FY26, Anupam Rasayan India Ltd's management highlighted

  • "The Jayhawk integration is now complete and we've already secured long-term contracts with three global agrochemical majors. This facility will contri..."
  • "We've invested ₹650 crores in capex this year, primarily toward the Jayhawk integration and Mundra expansion. Our total capex for FY26 will be around ..."
  • "Our OPM expansion to 22.5% reflects both operating leverage and our successful transition to higher-value products. We expect margins to further impro..."

What is Anupam Rasayan India Ltd's management guidance for growth?

Anupam Rasayan India Ltd's management has provided the following forward guidance for FY27

  • Revenue growth target: 35%
  • Implied PAT growth: 38%
  • OPM guidance: 23.5%
  • Capex plan: ₹800 Cr
  • Management tone: bullish
  • Milestone: Jayhawk integration completion
  • Milestone: Mundra Phase II ramp-up

Is Anupam Rasayan India Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Anupam Rasayan India Ltd may be worth studying

  • Earnings growing at +13.0% YoY

What is the investment thesis for Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd investment thesis summary:

Research Signals (Bull Case)

  • Revenue growing at +31.3% YoY
  • Growth catalyst: Jayhawk integration completion

Risk Factors (Bear Case)

  • Margins under pressure
  • Appears significantly overvalued
  • Key risk: RM volatility for benzene derivatives

What is the future outlook for Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd's forward outlook based on current data signals

  • Earnings Trend: stable
  • Revenue Trend: stable
  • Margin Trend: volatile
  • Valuation: Significantly Overvalued
  • Key Catalyst: Jayhawk integration completion
  • Key Risk: RM volatility for benzene derivatives

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.